Aditxt Announces 1-for-27 Reverse Stock Split to Regain Nasdaq Compliance

Aditxt Inc. (NASDAQ: ADTX), a social innovation platform focused on accelerating health innovations, announced it will implement a 1-for-27 reverse stock split of its common stock, effective at the opening of trading on the Nasdaq Capital Market on May 18, 2026. The move is designed to bring the company into compliance with Nasdaq’s minimum bid price requirement, a critical step for maintaining its listing on the exchange.

The reverse stock split will reduce the number of outstanding common shares from approximately 13.8 million to about 510,123, with the stock continuing to trade under the symbol ADTX. This corporate action is a common strategy for companies facing delisting due to low share prices, as it mechanically increases the per-share price without altering the underlying market capitalization.

Aditxt operates a unique model that democratizes innovation, ensuring every stakeholder’s voice is heard and valued. The company currently runs four programs focused on autoimmunity, cancer and early disease detection, infectious diseases, and women’s health. Its ecosystem includes research institutions, industry partners, and shareholders who collaboratively drive its mission to "Make Promising Innovations Possible Together."

The reverse split is a pivotal event for Aditxt as it seeks to stabilize its stock price and continue its operations on the Nasdaq. For more details, the full press release is available at https://ibn.fm/S1uMK. Investors can also find the latest news and updates regarding ADTX in the company’s newsroom at https://ibn.fm/ADTX.